[Molecular pathophysiology of late complications diabetes mellitus--hyperglycemia-induced changes]

K Kanková1

  • 1Ustav patologické fyziologie Lékarské fakulty MU, Brno.

Vnitrni Lekarstvi
|January 7, 2005
PubMed

Insights

Chronic diabetes mellitus leads to serious health issues like T2DM, impacting younger populations. Understanding diabetes complications, like hyperglycemia-induced glycolysis inhibition, is key to better treatments and patient outcomes.

Area of Science:

  • Endocrinology and Metabolism
  • Molecular Biology

Context:

  • Diabetes mellitus, particularly Type 2 Diabetes Mellitus (T2DM), is a growing global health concern with increasing incidence and a trend towards younger age groups.
  • Late diabetic complications arise from chronic hyperglycemia, affecting both vascular and extravascular systems, with disease duration and therapeutic control being significant factors.

Purpose:

  • To review recent findings on the pathogenesis of late diabetic complications, focusing on hyperglycemia-induced molecular alterations.
  • To elucidate the common pathogenic mechanisms, including glycolysis inhibition and cellular damage, that contribute to organ-specific manifestations of diabetes.

Summary:

  • Chronic hyperglycemia in diabetes mellitus triggers proximal molecular events, notably inhibiting glycolysis at the Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) level via an increased NADH/NAD+ ratio.
  • This inhibition, coupled with increased superoxide generation and intracellular dicarbonyl accumulation, activates gene expression leading to tissue remodeling and characteristic organ damage.
  • Secondary prevention and minimizing late complications are achievable goals, necessitating a deeper understanding of diabetes pathogenesis and identification of high-risk individuals.

Impact:

  • Improved understanding of diabetes pathogenesis can lead to enhanced therapeutic strategies and better patient prognoses.
  • Identifying high-risk individuals for diabetic complications will allow for targeted interventions and personalized medicine approaches.
  • This review provides a foundation for future research into the genetic susceptibility of developing late diabetic complications.

Related Concept Videos

Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...